Reassessing The Changing Outlook For Teva- Pharmaceutical Industries Ltd. ADR (TEVA)
Ion Asset Management recently announced the acquisition of new stake in Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA). The institutional investor has increased its shareholding in the Healthcare company by 17.42% to 38.82 million shares with purchase of 5.76 million shares. This fresh investment now brings its stake to 3.46% valued currently at $405.31 million. In […]
Do Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Fit In A Value Investing Philosophy?
Ion Asset Management recently announced the acquisition of new stake in Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA). The institutional investor has increased its shareholding in the Healthcare company by 17.42% to 38.82 million shares with purchase of 5.76 million shares. This fresh investment now brings its stake to 3.46% valued currently at $381.24 million. In […]
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Is Getting Increasingly Hard To Ignore
Ion Asset Management recently announced the acquisition of new stake in Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA). The institutional investor has increased its shareholding in the Healthcare company by 17.42% to 38.82 million shares with purchase of 5.76 million shares. This fresh investment now brings its stake to 3.46% valued currently at $381.24 million. In […]
Now Is A Suitable Moment For A Long-Term Purchase Of Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA)
Ion Asset Management recently announced the acquisition of new stake in Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA). The institutional investor has increased its shareholding in the Healthcare company by 17.42% to 38.82 million shares with purchase of 5.76 million shares. This fresh investment now brings its stake to 3.46% valued currently at $381.24 million. In […]
